Clik here to view.
Tuesday’s prostate cancer news reports: February 3, 2008
With the exception of a paper on baseline erectile dysfunction in patients undergoing radical prostatectomy, today’s news reports are filled with esoterica that are likely to be of interest only to...
View ArticleClik here to view.
Better identification of potentially good responders to prostate cancer...
A paper just published in Clinical Cancer Research has suggested that — at least for one immunotherapeutic agent (“vaccine”) in development for the treatment of advanced prostate cancer — it may be...
View ArticleProstate cancer and treatment with immune checkpoint inhibitors
Immune checkpoint inhibitors include drugs like ipilimumab (Yervoy), pembrolizumab (Keytruda), nivolumab (Opdivo), and others that can have dramatic effects on the survival of some groups of patients...
View ArticleCAR-T used in treatment of two men with mCRPC at UPenn
On a CureTalks conversation earlier today with Dr. Carl June of the University of Pennsylvania (UPenn), we learned that his team had very recently treated two men with metastatic, castration-resistant...
View Article
